Targeting oncometabolism to maximize immunotherapy in malignant brain tumors. Bernstock JD, Kang KD, Klinger NV, Olsen HE, et al. Oncogene 2022 Apr 16. pii: 10.1038/s41388-022-02312.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bernstock JD, Kang KD, Klinger NV, Olsen HE, et al. Targeting oncometabolism to maximize immunotherapy in malignant brain tumors. Oncogene 2022 Apr 16. pii: 10.1038/s41388-022-02312.
PMID: 35430605